Hilton cuts 2024 room revenue growth forecast as US consumers trim travel spending-February 2024-www.financetom.com

Hilton cuts 2024 room revenue growth forecast as US consumers trim travel spending

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Hilton cuts 2024 room revenue growth forecast as US consumers trim travel spending

Oct 23, 2024 3:26 AM

Oct 23 (Reuters) - Hilton Worldwide ( HLT ) lowered its

annual room revenue growth forecast on Wednesday, as some U.S.

consumers cut back on domestic travel spending amid a drop in

disposable income.

The company now expects system-wide 2024 room revenue

growth to be between 2% and 2.5%, compared with its prior range

of 2% to 3%.

Previous page： Jet.AI Q3 revenue falls 56%, operating loss narrows Next page： Sable Offshore Disputes Hunterbrook's Claims on Accounts, Bonding

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Jet.AI Q3 revenue falls 56%, operating loss narrows

Nov 14, 2025

Overview * Jet.AI ( JTAI ) Q3 revenue declines to $1.7 mln from $3.9 mln last year * Company reports operating loss of $2 mln, an improvement from $2.9 mln last year * Jet.AI ( JTAI ) progresses on Canadian Hyperscale Data Center Project, completing second milestone Outlook * Jet.AI ( JTAI ) prioritizes completing third milestone of Canadian data...

Sable Offshore Disputes Hunterbrook's Claims on Accounts, Bonding

Nov 14, 2025

04:42 PM EST, 11/14/2025 (MT Newswires) -- Sable Offshore ( SOC ) on Friday disputed certain inaccuracies in a report by investment firm Hunterbrook regarding its accounts payable, ownership and bonding requirements with ExxonMobil ( XOM ) . The company clarified that its accounts payable as of September 30, was approximately $53 million, not the $163 million cited in Hunterbrook's...

Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.

Nov 14, 2025

- Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share - - Transaction expected to close in the first quarter of 2026 - - Additional portfolio monetization efforts continue - - Company reports 3Q 2025 financial results - - $112.6 million in cash and cash equivalents and marketable securities as of September 30,...

Beam Global Q3 revenue misses estimates

Nov 14, 2025

Overview * Beam Global ( BEEM ) Q3 revenue fell 50% yr/yr, missing analyst expectations * Net loss for Q3 missed analyst estimates * Company expanded into Middle East with new joint venture Outlook * Beam Global ( BEEM ) anticipates growth from Middle East expansion due to $1 trillion infrastructure investment, in the next decade * Company expects revenue...